Access cutting-edge chronic kidney disease treatment through this clinical trial at a research site in Oklahoma City. Study-provided care at no cost to qualified participants.
Access chronic kidney disease specialists in Oklahoma City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic kidney disease treatment provided free
This is a Phase 3 Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
Sponsor: Amgen
Check if you qualify for this chronic kidney disease clinical trial in Oklahoma City, OK
If you're searching for chronic kidney disease treatment options in Oklahoma City, OK, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Oklahoma City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic kidney disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.